{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:02:47Z","timestamp":1784739767025,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00164"],"award-info":[{"award-number":["PI17\/00164"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["2021 SGR 00452"],"award-info":[{"award-number":["2021 SGR 00452"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["AGAUR-FI_B 00582"],"award-info":[{"award-number":["AGAUR-FI_B 00582"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["MSD LKR 155762"],"award-info":[{"award-number":["MSD LKR 155762"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ebiom.2025.106070","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T19:34:45Z","timestamp":1765308885000},"page":"106070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["PD-1 blockade enhances functional vaccine-induced HIV-1 CD8+ T-cell responses in PWH receiving early ART"],"prefix":"10.1016","volume":"123","author":[{"given":"Miguel","family":"Marin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Jimenez-Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Blanch-Lombarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-9546","authenticated-orcid":false,"given":"Tomas","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-9943","authenticated-orcid":false,"given":"Bonnie","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-4645","authenticated-orcid":false,"given":"Julia G.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.106070_bib1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.106070_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection","volume":"407","author":"Rosenberg","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.106070_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00002030-200301240-00009","article-title":"HIV RNA in plasma rebounds within days during structured treatment interruptions","volume":"17","author":"Fischer","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2025.106070_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.862270","article-title":"Insights into persistent HIV-1 infection and functional cure: novel capabilities and strategies","volume":"13","author":"Ta","year":"2022","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106070_bib5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2022.06.002","article-title":"An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection","volume":"43","author":"Lichterfeld","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ebiom.2025.106070_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.molmed.2017.08.006","article-title":"Targeted immune interventions for an HIV-1 cure","volume":"23","author":"Perreau","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ebiom.2025.106070_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coviro.2016.02.001","article-title":"Which therapeutic strategy will achieve a cure for HIV-1?","volume":"18","author":"Cillo","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ebiom.2025.106070_bib8","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/JVI.00020-15","article-title":"Clinical control of HIV-1 by cytotoxic T cells specific for multiple conserved epitopes","volume":"89","author":"Murakoshi","year":"2015","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106070_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/14760584.2019.1675518","article-title":"Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials","volume":"18","author":"Hanke","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ebiom.2025.106070_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2567.2011.03517.x","article-title":"T-cell-inducing vaccines - what's the future","volume":"135","author":"Gilbert","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.ebiom.2025.106070_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"Harty","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2025.106070_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106070_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41591-020-0774-y","article-title":"Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption","volume":"26","author":"Colby","year":"2020","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106070_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184929","article-title":"Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B","volume":"12","author":"Ros\u00e1s-Umbert","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.106070_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2015.05.001","article-title":"HIV therapeutic vaccines: moving towards a functional cure","volume":"35","author":"Mylvaganam","year":"2015","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106070_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/655468","article-title":"AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-Infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein","volume":"202","author":"Schooley","year":"2010","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106070_bib17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","article-title":"Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021","volume":"27","author":"Deeks","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.106070_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00310","article-title":"Inhibitory receptors beyond T cell exhaustion","volume":"6","author":"Fuertes Marraco","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.106070_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.106070_bib20","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20061496","article-title":"PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection","volume":"203","author":"Petrovas","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2025.106070_bib21","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106070_bib22","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.4049\/jimmunol.1003870","article-title":"Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection","volume":"186","author":"Allie","year":"2011","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106070_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106070_bib24","doi-asserted-by":"crossref","first-page":"e1000882","DOI":"10.1371\/journal.ppat.1000882","article-title":"Galectin-9\/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response","volume":"6","author":"Sehrawat","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2025.106070_bib25","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/eji.200737857","article-title":"Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques","volume":"38","author":"Hokey","year":"2008","journal-title":"Eur J Immunol"},{"issue":"7109","key":"10.1016\/j.ebiom.2025.106070_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106070_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106070_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","article-title":"PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals","volume":"10","author":"Fromentin","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106070_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03350-23","article-title":"A follow-up study: 6-year cART-free virologic control of rhesus macaques after PD-1-based DNA vaccination against pathogenic SHIV SF162P3CN challenge","volume":"11","author":"He","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ebiom.2025.106070_bib30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.4049\/jimmunol.182.2.980","article-title":"PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination","volume":"182","author":"Finnefrock","year":"2009","journal-title":"J Immunol"},{"issue":"63","key":"10.1016\/j.ebiom.2025.106070_bib31","doi-asserted-by":"crossref","first-page":"eabh3034","DOI":"10.1126\/sciimmunol.abh3034","article-title":"PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8+ T cells in lymphoid tissue","volume":"6","author":"Rahman","year":"2021","journal-title":"Sci Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106070_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"June","key":"10.1016\/j.ebiom.2025.106070_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eclinm.2019.05.009","article-title":"Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)","volume":"11","author":"Mothe","year":"2019","journal-title":"eClinicalMedicine"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106070_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"L\u00e9tourneau","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.106070_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83737","article-title":"Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART","volume":"12","author":"Blanch-Lombarte","year":"2023","journal-title":"Elife"},{"issue":"16","key":"10.1016\/j.ebiom.2025.106070_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92901","article-title":"HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal","volume":"2","author":"Wu","year":"2017","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106070_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02296-16","article-title":"Ultrasensitive HIV-1 p24 assay detects single Iinfected cells and differences in reservoir induction by latency reversal agents","volume":"91","author":"Passaes","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.106070_bib38","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"Van Der Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106070_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2018.05.017","article-title":"Generalizable and scalable visualization of single-cell data using neural networks","volume":"7","author":"Cho","year":"2018","journal-title":"Cell Syst"},{"key":"10.1016\/j.ebiom.2025.106070_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-Driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.106070_bib41","doi-asserted-by":"crossref","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","article-title":"Fast unfolding of communities in large networks","volume":"2008","author":"Blondel","year":"2008","journal-title":"J Stat Mech"},{"key":"10.1016\/j.ebiom.2025.106070_bib42","series-title":"R: a language and environment for statistical computing","year":"2017"},{"issue":"D1","key":"10.1016\/j.ebiom.2025.106070_bib43","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"7235","key":"10.1016\/j.ebiom.2025.106070_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in vivo by PD-1 blockade","volume":"458","author":"Velu","year":"2009","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106070_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41591-020-0782-y","article-title":"CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption","volume":"26","author":"Harper","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.106070_bib46","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1038\/s41591-025-03993-0","article-title":"Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study","volume":"31","author":"Ramgopal","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.106070_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2020.00823","article-title":"HIVconsv vaccines and romidepsin in early-treated HIV-1-Infected individuals: safety, immunogenicity and effect on the viral reservoir (Study BCN02)","volume":"11","author":"Mothe","year":"2020","journal-title":"Front Immunol"},{"issue":"33","key":"10.1016\/j.ebiom.2025.106070_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202148119","article-title":"PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques","volume":"119","author":"Velu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106070_bib49","doi-asserted-by":"crossref","first-page":"e0181382","DOI":"10.1371\/journal.pone.0181382","article-title":"Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA\/simian adenovirus\/MVA vaccine regimens","volume":"12","author":"Moyo","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106070_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155251","article-title":"Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy","volume":"132","author":"Harper","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2025.106070_bib51","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1200\/JCO.2022.40.16_suppl.2504","article-title":"Phase 1 trial of TIM-3 inhibitor cobolimab monotherapy and in combination with PD-1 inhibitors nivolumab or dostarlimab (AMBER)","volume":"40","author":"Falchook","year":"2022","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106070_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad694","article-title":"Safety and immune responses following Anti-PD-1 monoclonal antibody infusions in healthy persons with human immunodeficiency virus on antiretroviral therapy","volume":"11","author":"Gay","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106070_bib53","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/QAI.0000000000002716","article-title":"Suspected immune-related adverse events with an Anti-PD-1 inhibitor in otherwise healthy people with HIV","volume":"87","author":"Gay","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"475","key":"10.1016\/j.ebiom.2025.106070_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy","volume":"11","author":"Barber","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2025.106070_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1018202","article-title":"Checkpoint inhibitors as immunotherapy for fungal infections: promises, challenges, and unanswered questions","volume":"13","author":"Wurster","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.106070_bib36","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106070_bib37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12094-018-1981-6","article-title":"Cancer immunotherapy of patients with HIV infection","volume":"21","author":"Gonzalez-Cao","year":"2019","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106070_bib56","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamaoncol.2020.0465","article-title":"Assessment of the feasibility and safety of Durvalumab for treatment of solid tumors in patients with HIV-1 infection: the phase 2 DURVAST study","volume":"6","author":"Gonzalez-Cao","year":"2020","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106070_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122089","article-title":"Enhancement of antiviral CD8+ T-Cell responses and complete remission of metastatic melanoma in an HIV-1-Infected subject treated with pembrolizumab","volume":"8","author":"Blanch-Lombarte","year":"2019","journal-title":"J Clin Med"},{"issue":"33","key":"10.1016\/j.ebiom.2025.106070_bib58","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1200\/JCO.2017.73.7338","article-title":"Modernizing clinical trial eligibility criteria: recommendations of the American society of clinical oncology-friends of cancer research HIV working group","volume":"35","author":"Uldrick","year":"2017","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106070_bib59","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/QAD.0000000000000314","article-title":"Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease","volume":"28","author":"Cockerham","year":"2014","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.ebiom.2025.106070_bib60","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1182\/blood-2010-11-317297","article-title":"Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection","volume":"117","author":"Yamamoto","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106070_bib61","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40262-019-00748-2","article-title":"Clinical pharmacokinetics and pharmacodynamics of immune checkpoint inhibitors","volume":"58","author":"Centanni","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"DEC","key":"10.1016\/j.ebiom.2025.106070_bib62","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3389\/fimmu.2017.01597","article-title":"PD-1\/PD-L1 blockade: have we found the key to unleash the antitumor immune response?","volume":"8","author":"Xu-Monette","year":"2017","journal-title":"Front Immunol"},{"issue":"7947","key":"10.1016\/j.ebiom.2025.106070_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-022-05538-8","article-title":"Phenotypic signatures of immune selection in HIV-1 reservoir cells","volume":"614","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106070_bib64","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106070_bib65","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1038\/s41591-022-02060-2","article-title":"Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial","volume":"28","author":"Bail\u00f3n","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106070_bib66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41541-024-00876-2","article-title":"Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy","volume":"9","author":"Julg","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106070_bib67","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-025-57284-w","article-title":"Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial","volume":"16","author":"Bail\u00f3n","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.106070_bib68","article-title":"Correlates of HIV-1 control after combination immunotherapy","author":"Peluso","year":"2025","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106070_bib69","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2010-12-328070","article-title":"Responsiveness of HIV-specific CD4 T cells to PD-1 blockade","volume":"118","author":"Porichis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2025.106070_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104254","article-title":"Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function","volume":"84","author":"Brunet-Ratnasingham","year":"2022","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106070_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2010.03259.x","article-title":"The potential of CD4 T-cell memory","volume":"130","author":"McKinstry","year":"2010","journal-title":"Immunology"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:10:30Z","timestamp":1773897030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425005201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":73,"alternative-id":["S2352396425005201"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106070","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1 blockade enhances functional vaccine-induced HIV-1 CD8+ T-cell responses in PWH receiving early ART","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106070"}}